Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Thermo Fisher Scientific has acquired Affinity BioReagents, a provider of antibodies, peptides, proteins and other reagents for life science research, based in Golden, Colorado.
Subscribe to our email newsletter
Affinity BioReagents provides recombinant proteins and custom antibody-production services. The company had annual revenues of approximately $6 million in 2007, and will be integrated into Thermo Fisher’s analytical technologies segment.
Marijn Dekkers, president and CEO of Thermo Fisher, said: “This acquisition enhances our extensive antibody portfolio, which will drive growth as we combine these reagents with our current proteomics offerings to create end-to-end solutions for widely used protein-research applications.”